Summary
The report forecast global Radiopharmaceuticals in Nuclear Medicine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Radiopharmaceuticals in Nuclear Medicine industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Radiopharmaceuticals in Nuclear Medicine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Radiopharmaceuticals in Nuclear Medicine market for 2016-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Radiopharmaceuticals in Nuclear Medicine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Radiopharmaceuticals in Nuclear Medicine company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Others
The report forecast global Radiopharmaceuticals in Nuclear Medicine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Radiopharmaceuticals in Nuclear Medicine industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Radiopharmaceuticals in Nuclear Medicine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Radiopharmaceuticals in Nuclear Medicine market for 2016-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Radiopharmaceuticals in Nuclear Medicine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Radiopharmaceuticals in Nuclear Medicine company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)
Market by Type
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Market by Application
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Others
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020
1.4 By Application
Table Application of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020
1.5 By Region
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020
Figure Asia Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020
Part 2 Key Companies
2.1 Bracco Imaging S.P.A.
2.1.1 Company Profile
Table Bracco Imaging S.P.A. Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Radiopharmaceuticals in Nuclear Medicine Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Cambridge Isotope Laboratories, Inc.
2.3 Cardinal Health, Inc.
2.4 Covidien, Plc
2.5 Eczacibasi-Monrol
2.6 Fujifilm Holdings Corporation
2.7 GE Healthcare (Subsidiary Of General Electric Company)
2.8 IBA Group
2.9 Isotec, Inc. (Sigma-Aldrich)
2.10 Lantheus Medical Imaging, Inc.
2.11 Nordion, Inc.
2.12 Ntp Radioisotopes (Pty), Ltd.
2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
2.14 Taiyo Nippon Sanso Corporation
2.15 Urenco Limited
2.16 Rotem Industries, Ltd., Inc.
2.17 Australian Nuclear Association And Technology Organization (ANSTO)
2.18 Board of Radiation And Isotope Technology (BRIT)
2.19 Institute of Atomic Energy Polatom Radioisotope Centre
2.20 Institute of Isotopes Co., Ltd.
2.21 Institute Of Radioelement (IRE)
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Region, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Region, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020 (Volume)
Table Price List by Region, 2016-2020
3.2 Global Market by Company
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Company, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Company, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company in 2020 (Volume)
Table Price List by Company, 2016-2020
3.3 Global Market by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
3.4 Global Market by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
3.5 Global Market by Forecast
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
5.2 Europe Market by Application
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.4 Europe Market by Forecast
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
6.2 North America Market by Application
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.4 North America Market by Forecast
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
7.2 South America Market by Application
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.4 South America Market by Forecast
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020
1.4 By Application
Table Application of Radiopharmaceuticals in Nuclear Medicine
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020
1.5 By Region
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020
Figure Asia Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020
Part 2 Key Companies
2.1 Bracco Imaging S.P.A.
2.1.1 Company Profile
Table Bracco Imaging S.P.A. Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Radiopharmaceuticals in Nuclear Medicine Business Operation of Bracco Imaging S.P.A. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Cambridge Isotope Laboratories, Inc.
2.3 Cardinal Health, Inc.
2.4 Covidien, Plc
2.5 Eczacibasi-Monrol
2.6 Fujifilm Holdings Corporation
2.7 GE Healthcare (Subsidiary Of General Electric Company)
2.8 IBA Group
2.9 Isotec, Inc. (Sigma-Aldrich)
2.10 Lantheus Medical Imaging, Inc.
2.11 Nordion, Inc.
2.12 Ntp Radioisotopes (Pty), Ltd.
2.13 Siemens Healthcare (Subsidiary Of Siemens AG)
2.14 Taiyo Nippon Sanso Corporation
2.15 Urenco Limited
2.16 Rotem Industries, Ltd., Inc.
2.17 Australian Nuclear Association And Technology Organization (ANSTO)
2.18 Board of Radiation And Isotope Technology (BRIT)
2.19 Institute of Atomic Energy Polatom Radioisotope Centre
2.20 Institute of Isotopes Co., Ltd.
2.21 Institute Of Radioelement (IRE)
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Region, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Region, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Region in 2020 (Volume)
Table Price List by Region, 2016-2020
3.2 Global Market by Company
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Company, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Company, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Company in 2020 (Volume)
Table Price List by Company, 2016-2020
3.3 Global Market by Type
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
3.4 Global Market by Application
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Global Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
3.5 Global Market by Forecast
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure China Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure India Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
5.2 Europe Market by Application
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Germany Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure UK Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure France Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Spain Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
5.4 Europe Market by Forecast
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
6.2 North America Market by Application
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table North America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure United States Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Canada Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
6.4 North America Market by Forecast
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure North America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
7.2 South America Market by Application
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table South America Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Chile Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Peru Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
7.4 South America Market by Forecast
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Million USD)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Type, 2016-2020 (Volume)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Million USD)
Table Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market by Application, 2016-2020 (Volume)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure GCC Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Million USD)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Market Status, 2016-2020 (Volume)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Market Forecast, 2021E-2026F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion
